bladder tumor

Journal Title, Volume, Page:

Turkish Journal of Urology 2010;36(2):119-124

Year of Publication:

2010

Link:

http://turkurolojidergisi.com/eng/ozet/91/9/Abstract

Authors:

Mahmoud Mustafa

Osmaniye State Hospital, Urology Department, Osmaniye, Turkey

Current Affiliation:

Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine

[email protected]

Tamer S. Barakat

Mansoura University, Urology and Nephrology Center, Mansoura, Egypt

Bedier Ali-El-Edein

Mansoura University, Urology and Nephrology Center, Mansoura, Egypt

Preferred Abstract (Original):

Urothelial cancer staged as T1G3 presents urologist with challenges, because it has poor outcome if treated as superficial bladder tumor. Transurethral resection is the standard treatment for the non-muscle-invasive bladder tumor. However, high-grade T1 bladder tumor has potentially bad prognosis and transurethral resection is not adequate treatment option. The recurrence rate after transurethral resection is 50-80% and progression rate to muscle-invasive disease is 27-63%. The treatment of choice for patients with high grade T1 bladder tumor is a matter of controversy. Herein, we reviewed the literature and guidelines regarding the management of patients diagnosed with high-grade T1 urothelial cancer.

An-Najah Staff

Management of Bladder Transitional Cell Carcinoma In Stage T1G3